Anti-Human TNFRSF9/CD137 Rabbit Recombinant Antibody
TNFRSF9/CD137 Recombinant Antibody for FC
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
FC
Conjugate
Unconjugated
CloneNo.
241344F3
Cat no : 98112-1-RR
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | Con-A-stimulated human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
98112-1-RR targets TNFRSF9/CD137 in FC applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | Recombinant Protein 相同性解析による交差性が予測される生物種 |
Full Name | tumor necrosis factor receptor superfamily, member 9 |
Calculated molecular weight | 28 kDa |
GenBank accession number | BC006196 |
Gene symbol | TNFRSF9/CD137 |
Gene ID (NCBI) | 3604 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purfication |
Storage Buffer | PBS with 0.09% sodium azide, pH 7.3. |
Storage Conditions | Store at 2 - 8°C. Stable for one year after shipment. |
Background Information
CD137, also known as TNFRSF9 or 4-1BB, is an inducible T cell surface receptor that belongs to the tumor necrosis factor receptor superfamily. CD137 is a transmembrane protein expressed on the surface of activated T-cells. In addition, activation-dependent expression of CD137 has also been found in B lymphocytes, monocytes, and diverse nonlymphoid cell types. CD137 provides a co-stimulatory signal that enhances the survival, and differentiation of cells, and has a crucial role in the development of CD8 cytotoxic T cells and anti-tumor immunity. (PMID: 9826581; 23696891)
Protocols
Product Specific Protocols | |
---|---|
FC protocol for TNFRSF9/CD137 antibody 98112-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |